Notable
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
Primary completion pushed from Jun 1, 2025 to Sep 1, 2027
Also in this update: Enrollment closed, study ongoing; Study completion pushed from Jun 1, 2025 to Oct 1, 2027
Douglas SealsPhase 2 NCT03821623 Registry history of NCT03821623 on ClinicalTrials.gov (opens the registry)